368 related articles for article (PubMed ID: 18698463)
21. Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.
Giraud F; Alves G; Debiton E; Nauton L; Théry V; Durieu E; Ferandin Y; Lozach O; Meijer L; Anizon F; Pereira E; Moreau P
J Med Chem; 2011 Jul; 54(13):4474-89. PubMed ID: 21623630
[TBL] [Abstract][Full Text] [Related]
22. Syntheses of novel heterocycles as anticancer agents.
Chauhan PM; Martins CJ; Horwell DC
Bioorg Med Chem; 2005 May; 13(10):3513-8. PubMed ID: 15848764
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and cytotoxic activities of novel phenacylimidazolium bromides.
Yang XD; Zeng XH; Zhang YL; Qing C; Song WJ; Li L; Zhang HB
Bioorg Med Chem Lett; 2009 Apr; 19(7):1892-5. PubMed ID: 19269816
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents.
Alkahtani HM; Abbas AY; Wang S
Bioorg Med Chem Lett; 2012 Feb; 22(3):1317-21. PubMed ID: 22225635
[TBL] [Abstract][Full Text] [Related]
25. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.
Harmange JC; Weiss MM; Germain J; Polverino AJ; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; DiPietro L; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Martin MW; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Wang L; White RD; Whittington DA; Zanon R
J Med Chem; 2008 Mar; 51(6):1649-67. PubMed ID: 18324761
[TBL] [Abstract][Full Text] [Related]
26. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumour activity of new muricatacin and goniofufurone analogues.
Popsavin V; Srećo B; Krstić I; Popsavin M; Kojić V; Bogdanović G
Eur J Med Chem; 2006 Oct; 41(10):1217-22. PubMed ID: 16891043
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and in vitro cytotoxic studies of novel bis-pyrrolo[2,1][1,4] benzodiazepine-pyrrole and imidazole polyamide conjugates.
Kumar R; Lown JW
Eur J Med Chem; 2005 Jul; 40(7):641-54. PubMed ID: 15935899
[TBL] [Abstract][Full Text] [Related]
30. Spiroindimicins A-D: new bisindole alkaloids from a deep-sea-derived actinomycete.
Zhang W; Liu Z; Li S; Yang T; Zhang Q; Ma L; Tian X; Zhang H; Huang C; Zhang S; Ju J; Shen Y; Zhang C
Org Lett; 2012 Jul; 14(13):3364-7. PubMed ID: 22694269
[TBL] [Abstract][Full Text] [Related]
31. Potential antitumor agents. 34.(1) Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from diimidazo[1,2-a: 1,2-c] pyrimidine.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Giorgi G; Garaliene V
Anticancer Res; 2004; 24(1):203-11. PubMed ID: 15015598
[TBL] [Abstract][Full Text] [Related]
32. Aza-analogues of the marine pyrroloquinoline alkaloids wakayin and tsitsikammamines: synthesis and topoisomerase inhibition.
Legentil L; Lesur B; Delfourne E
Bioorg Med Chem Lett; 2006 Jan; 16(2):427-9. PubMed ID: 16242321
[TBL] [Abstract][Full Text] [Related]
33. Calothrixins, a new class of human DNA topoisomerase I poisons.
Khan QA; Lu J; Hecht SM
J Nat Prod; 2009 Mar; 72(3):438-42. PubMed ID: 19203291
[TBL] [Abstract][Full Text] [Related]
34. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiproliferative activities of isoindigo and azaisoindigo derivatives.
Bouchikhi F; Anizon F; Moreau P
Eur J Med Chem; 2008 Apr; 43(4):755-62. PubMed ID: 17628214
[TBL] [Abstract][Full Text] [Related]
37. In vitro primary antitumor screen of imidazole platinum complexes.
Kuduk-Jaworska J
Arch Immunol Ther Exp (Warsz); 1994; 42(1):77-82. PubMed ID: 7503641
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of (±)-actinophyllic acid and analogs: applications of cascade reactions and diverted total synthesis.
Granger BA; Jewett IT; Butler JD; Hua B; Knezevic CE; Parkinson EI; Hergenrother PJ; Martin SF
J Am Chem Soc; 2013 Sep; 135(35):12984-6. PubMed ID: 23972114
[TBL] [Abstract][Full Text] [Related]
39. Amidine analogues of melphalan: synthesis, cytotoxic activity, and DNA binding properties.
Bielawska A; Bielawski K; Anchim T
Arch Pharm (Weinheim); 2007 May; 340(5):251-7. PubMed ID: 17458920
[TBL] [Abstract][Full Text] [Related]
40. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
